Skip to main content
Letters in Drug Design & Discovery publishes original letters on all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis will be on publishing quality papers very rapidly. Letters will be processed rapidly by taking full advantage of Internet technology for both the submission and review of manuscripts. The journal is essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

Publisher: Bentham Science Publishers

More about this publication?
Volume 11, Number 5, 2014

Articles

Free Content Graphical Abstracts
pp. i-viii(8)

Favourites:
ADD

Synthesis of Oxygenated Chalcones with Anti-Staphylococcal Activity
pp. 525-530(6)
Authors: Dalla-Vechia, Luciana; Janine Kiekow, Cintia; Correa Ramos Leal, Ivana; Regina Netto Dos Santos, Katia; Cristina Baggio Gnoatto, Simone; Verli, Hugo; Octavio Mendonca Alves de Souza, Rodrigo; Gosmann, Grace

Favourites:
ADD

Designing New 5-Nitroimidazoles: Towards Safer Anti-infectious Agents
pp. 531-559(29)
Authors: D. Crozet, Maxime; Terme, Thierry; Vanelle, Patrice

Favourites:
ADD

Novel Urea/Thiourea Derivatives of Quinazolin-4(3H)-one: Design, Synthesis, Antimicrobial and Anti-TB Study
pp. 560-571(12)
Authors: R. Shah, Dhruvin; P. Modh, Rahul; V. Desai, Dhara; H. Chikhalia, Kishor

Favourites:
ADD
Favourites:
ADD

Synthesis and Anticancer Activity of Some 2-[3/4-(2-Substituted Phenyl-2- oxoethoxy)benzylidene]-6-substituted-2,3-dihydro-1H-inden-1-one Derivatives
pp. 578-585(8)
Authors: Gundogdu-Karaburun, Nalan; Cagri Karaburun, Ahmet; Demirayak, Seref; Kayagil, Ismail; Yurttas, Leyla

Favourites:
ADD

Synthesis and Antitumor Activities of α-,γ-mangostin Derivatives
pp. 586-593(8)
Authors: Cheng, Kai; Zhang, Gui-lin; Qiu, Sheng-xiang; Liu, Yan-qing; Wang, Yan-fei; Liu, Song; Shan, Yan; Yu, Bo; Lu, Yu

Favourites:
ADD

A Facile Synthesis and Anticancer Activity Evaluation of Spiro Analogues of Benzothiazolylchromeno/pyrano Derivatives
pp. 594-600(7)
Authors: Kumar Arya, Anand; Rana, Kulbhushan; Kumar, Mahendra

Favourites:
ADD
Favourites:
ADD

Potent Neuroprotective Activity of Monoterpene Derived 4-[(3aR,7aS)- 1,3,3a,4,5,7a-Hexahydro-3,3,6-trimethylisobenzofuran-1-yl]-2-methoxyphenol in MPTP Mice Model
pp. 611-617(7)
Authors: V. Pavlova, Alla; V. Il'ina, Irina; A. Morozova, Ekaterina; V. Korchagina, Dina; Yu. Kurbakova, Svetlana; V. Sorokina, Irina; G. Tolstikova, Tatyana; P. Volcho, Konstantin; F. Salakhutdinov, Nariman

Favourites:
ADD

QSAR Study on Diketo Acid and Carboxamide Derivatives as Potent HIV- 1 Integrase Inhibitor
pp. 618-627(10)
Authors: Olayide Adebimpe, Arodola; Charan Dash, Radha; E. S. Soliman, Mahmoud

Favourites:
ADD

Synthesis and Anticonvulsant Activity Evaluation of 4-butyl-5-(4- alkoxyphenyl)-2H-1,2,4-triazole-3(4H)-ones
pp. 628-635(8)
Authors: Zhu, Zi-Shi; Wang, Shi-Ben; Deng, Xian-Qing; Liu, Da-Chuan; Quan, Zhe-Shan

Favourites:
ADD

Artificial Neural Networks Modeling of Release of Olanzapine From Glycerol Monooleate Matrices
pp. 636-648(13)
Authors: Bagheri, G.; Vasheghani-Farahani, E.; Ardjmand, M.; Attar, H.; A. Dorkoosh, F.

Favourites:
ADD

4D-QSAR Model for Compounds with Binding Affinity Towards Dopamine D2 Receptors
pp. 649-664(16)
Authors: Rodrigues Silva, Daniela; C. Ramalho, Teodorico; F. F. da Cunha, Elaine

Favourites:
ADD

A Combined DFT and QSAR Calculations to Study Substituted Biphenyl imidazoles as Bombesin Receptor Subtype-3 Agonists
pp. 665-676(12)
Authors: Shahlaei, Mohsen; Nowroozi, Amin; Khodarahmi, Reza

Favourites:
ADD

Synthesis and In Vivo Hepatoprotective Activity of Some Novel Andrographolide Derivatives
pp. 677-685(9)
Authors: Tang, Chunlei; Gu, Guolong; Yang, Baowei; Wang, Xuekun; Qian, Hai; Huang, Wenlong; Zhu, Xiaoyun; Li, Jing

Favourites:
ADD

Development of Pyrazole Compounds as Antidiabetic Agent: A Review
pp. 686-703(18)
Authors: A. Datar, Prasanna; R. Jadhav, Sonali

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content